COMMUNITY CLINICAL ONCOLOGY PROGRAM

社区临床肿瘤学计划

• 批准号: 3557468
• 负责人: RICHARD J ROSENBLUTH
• 金额: $ 7.66万
• 依托单位: HACKENSACK UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-01 至 1987-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3557468
• 关键词: cancer information system; cancer registry /resource; cancer rehabilitation /care; community health services; health science research analysis /evaluation; neoplasm /cancer education; patient /disease registry; patient care planning; pharmacy administration

The Bergen Passaic Community Hospital Oncology Program forms the foundation of the Bergen-Passaic Community Clinical Oncology Program. This consortium of three hospitals has already developed a solid core of cancer control programs in a community hospital setting. In addition, we have access to high quality equipment and staff that assure a strong base on which to build a CCOP. In Section II of our proposal we have outlined the specific aims and emphasized three basic components: structure and management, clinical research, and evaluation. We specifically cite (a) maintenance of a structural base which supports physician involvement, (b) maintenance of physician support for the total cancer program, (c) expansion of BP-CCOP physician involvement in protocol formulation and patient accrual, (d) establishment of standards of excellence, (e) participation in quality control measures, (f) provisions of extensive data to the NCI for evaluation, and (g) establishment of an integrated data collection system. We have paid special attention, in our Methodology Section, to the development of an appropriate system for patient identification, data collection, quality control and pharmacy procedures. These systems were developed with the idea that they were appropriate for our CCOP and would produce the highest quality clinical research.

该卑尔根帕塞伊克社区医院肿瘤学计划形成的基础 卑尔根-帕塞伊克社区临床肿瘤学项目 该联盟 三家医院已经建立了一个坚实的癌症控制核心 在社区医院的环境下。 此外，我们还可以访问 高素质的设备和工作人员，确保一个坚实的基础， 建立一个CCOP。 在我们的建议的第二部分，我们概述了具体的 目标，并强调三个基本组成部分：结构和管理， 临床研究和评估。 我们特别提到（a）维持 支持医师参与的结构基础，（B）维持 医生对全面癌症方案的支持，（c）扩大BP-CCOP 医生参与方案制定和患者招募，（d） 建立优良标准，（e）参与质量 （f）向NCI提供广泛的数据， （g）建立综合数据收集系统。 我们在方法部分特别注意了 开发适当的系统，用于患者识别、数据 收集、质量控制和药房程序。 这些系统 他们认为，他们是适合我们的CCOP的想法， 进行最高质量的临床研究。